Dr Clyde Yancy on the Persistence of Health Disparities in the US
September 30th 2024Clyde Yancy, MD, MSc, FHFSA, professor, chief of cardiology, and vice dean of diversity and inclusion at Northwestern University Feinberg School of Medicine, discusses progress made in health equity since the 1985 Heckler Report.
How Technological Innovations Could Improve CVD Risk Factor Management
September 26th 2024Benjamin Scirica, MD, MPH, director of quality initiatives at Brigham and Women’s Hospital’s Cardiovascular Division, discussed the importance of team-based care and gaps in technology to manage patients at risk of cardiovascular disease (CVD).
Greater Awareness, Community Empowerment Needed in CVD Prevention Efforts
September 25th 2024Laurence Sperling, MD, executive director of the Million Hearts initiative at the CDC and CMS, shared insight into population health strategies to address cardiovascular disease (CVD) prevention in at-risk populations.
Dr Amy Peterson on the Importance of Pediatric Lipid Screening
September 24th 2024Amy Peterson, MD, professor in the Department of Pediatrics at the University of Wisconsin, discussed current pediatric lipid screening guidelines and the potential evolution of pediatric lipid screening in the coming years.
Physical Activity Outweighs Sleep Duration in Lowering MAFLD Risk
August 16th 2024A new study found physical activity held more weight in the link between the joint exposure of sleep duration, metabolic equivalent of task, and Healthy Eating Index (HEI)-2015 and metabolic-associated fatty liver disease (MAFLD).
Black Patients Underrepresented in Pivotal Inflammatory Arthritis Clinical Trials
October 26th 2023While Black people are consistently underrepresented, White people are consistently overrepresented in inflammatory arthritis trials for rheumatoid arthritis, psoriatic arthritis, spondyloarthritis, and juvenile idiopathic arthritis.